An illustration of a Lockheed Martin concept for NASA's proposed Deep Space Gateway, with the Power and Propulsion Module on the right. Credit: Lockheed Martin WASHINGTON — NASA awarded contracts Nov.

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today presented interim data from the ongoing Phase 2 GATEWAY clinical study of ARO-ANG3, the company’s investigational ...